Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Preventive Nutrition

This article was originally published in The Tan Sheet

Executive Summary

GNC Cognita "neuro support" supplement will be promoted with coupons and brochures during Prevention magazine's six-month "Healthy Lifestyle Tour," which begins late May. July print ad campaign also planned in health-related publications including Prevention and Reader's Digest-Mature Edition, Royal Numico division says May 9. Bowel Support mid-June launch slated, with print ads scheduled to drop in August. Other Preventive Nutrition products shipped in March and will be backed by ads starting in August (1"The Tan Sheet" March 5, p. 11). Firm already has conducted direct mailing to 15,000 physicians to promote "science-based" supplements

You may also be interested in...



GNC Preventive Nutrition Promotions Target Grassroots Groups, Physicians

GNC is promoting the addition of 10 supplements to its Preventive Nutrition line by disseminating information through support groups and other grassroots organizations, as well as doctors. The premium products will be fully distributed to GNC stores by the end of March.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092552

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel